EXOZ - Invizyne Technologies Qarzning balans kapitallashuviga nisbati

Invizyne Technologies (EXOZ) grafik logotipi

Ushbu grafikdagi aksiya kotirovkalari eXoZymes Inc (EXOZ) biznesi uchun ko'rsatkich vazifasini o'taydi, u global resurslardan foydalanish va geosiyosiy qiyinchiliklarni yengib o'tishga tayanadi, shu bilan birga rahbariyat laboratoriya ishlanmalarini sanoat hajmiga yetkazmoqda, bu esa 0.29 ni tashkil etadi. Shu bilan birga, eXoZymes Inc (EXOZ) murakkab birikmalarni olishning xavfsiz va ekologik toza usullarini yaratish orqali sintetik biologiya sohasida yetakchi sifatidagi maqomini mustahkamlamoqda.

EXOZ (Invizyne) Qarzning balans qiymatiga nisbati tarixi 13.02.2025dan 27.10.2026gacha

Invizyne Technologies (EXOZ) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi eXoZymes Inc|EXOZ - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Invizyne|EXOZ - Qarz va naqd pullar hisobga olingan qiymat
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar eXoZymes|EXOZ - Kompaniyaning sof aktivlari|Bozor kapitallashuvining balans qiymatiga nisbati invizyne.com|EXOZ - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning xususiy kapitalga nisbati eXoZymes Inc|EXOZ - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Invizyne Technologies, Inc.|EXOZ - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans qiymatiga nisbati Invizyne
Kompaniyaning barcha koʻrsatkichlari tahlili:EXOZ eXoZymes Inc
Invizyne Technologies, Inc. asosiy tovari

Investorlar ushbu ko'rsatkichdan moliyaviy barqarorlikni baholash va aktivlarni ehtimoliy egallashdan oldin qarz yuklamasi limitini aniqlash uchun foydalanadilar. Yashil texnologiyalar sohasida AQShning qulay yurisdiksiyasida faoliyat yuritayotgan startap eXoZymes Inc (EXOZ) uchun qarzning kapitalizatsiyaga nisbati kapital xavfsizligi va kredit leveraj samaradorligi o'rtasidagi muvozanatni namoyish etib, kompaniyani past xavfli o'sish instrumenti sifatida tavsiflaydi.

eXoZymes Inc raqobatchilari

Balans kapitallashuviga qarzlar HLN (Haleon plc)|kenvue.com - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Verona Pharma (VRNA)|MENS: Qarzning sof aktivlarga nisbati|LGND (Ligand Pharma) - Qarzning balans kapitallashuviga nisbati|Amneal Corp (AMRX) - Qarzning balans qiymatiga nisbati|PRGO (Perrigo Company plc) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar alvotech.com (ALVO)|Liquidia (LQDA) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati GLPG (Galapagos N.V.)|ANIP: Qarzning balans kapitallashuviga nisbati|MNKD - Balans qiymatiga qarzlar|Qarzning balans qiymatiga nisbati Amphastar Pharmaceuticals AMPH|PCRX - Qarzning balans kapitaliga nisbati|Balans kapitallashuviga qarzlar ARS Pharmaceuticals, Inc. SPRY|Theravance Biopharma Inc (TBPH) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar AQST (Aquestive Pharma)|Balans qiymatiga qarzlar SCPH|Tectonic Therapeutic, Inc. (TECX) - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati tonixpharma.com (TNXP)|SXTC: Balans kapitallashuviga qarzlar|EPRX - Balans qiymatiga qarzlar|BioHarvest (BHST) - Qarzning balans qiymatiga nisbati|ORMP: Qarzning balans qiymatiga nisbati|Qarzning balans kapitallashuviga nisbati ENTX|Balans qiymatiga qarzlar ipatherapeutics.com|Qarzning balans qiymatiga nisbati ABVC BioPharma, Inc. ABVC|Qarzlarning balans kapitallashuviga nisbati Cumberland Pharmaceuticals Inc (CPIX)|Quantum BioPharma Limited - Qarzning balans qiymatiga nisbati|Balans qiymatiga qarzlar FGEN (FibroGen Corporation)|Telomir Pharmaceuticals - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati Rani Therapeutics Holdings RANI|SNYR (Synergy CHC Corporation) - Balans kapitallashuviga qarzlar|RLYB: Balans qiymatiga qarzlar|lexariabioscience.com - Qarzning balans kapitallashuviga nisbati|Sof aktivlarga qarzlar Pulmatrix Corporation|PTHL - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati Aptorum|LYRA (Lyra Therapeutics) - Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar IBO (Impact BioMedical, Inc.)|TNFA - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati cbdMD Inc. YCBD|PRFX: Balans kapitallashuviga qarzlar|CYTO - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar LIPO|Balans qiymatiga qarzlar OptiNose Inc|Qarzning balans qiymatiga nisbati Pieris (PIRS)|Qarzning balans qiymatiga nisbati PROC|Petros Pharmaceuticals - Qarzning balans kapitallashuviga nisbati|Balans qiymatiga qarzlar qlsyy.net QLI|ACELYRIN (SLRN) - Qarzning balans qiymatiga nisbati|TFF Pharmaceuticals Inc. - Qarzlarning balans kapitallashuviga nisbati